COMMONWEALTH EQUITY SERVICES, LLC - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 346 filers reported holding INTELLIA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 1.20 and the average weighting 0.1%.

Quarter-by-quarter ownership
COMMONWEALTH EQUITY SERVICES, LLC ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$962
-17.2%
30,415
+6.7%
0.00%0.0%
Q2 2023$1,162
+10.1%
28,505
+0.7%
0.00%0.0%
Q1 2023$1,055
+11.3%
28,309
+4.1%
0.00%0.0%
Q4 2022$948
-99.9%
27,186
+46.4%
0.00%
-33.3%
Q3 2022$1,039,000
-4.4%
18,572
-11.6%
0.00%0.0%
Q2 2022$1,087,000
-42.2%
21,005
-18.8%
0.00%
-25.0%
Q1 2022$1,880,000
-40.2%
25,875
-2.6%
0.00%
-42.9%
Q4 2021$3,142,000
-11.3%
26,579
+0.7%
0.01%
-22.2%
Q3 2021$3,541,000
-19.3%
26,397
-2.6%
0.01%
-18.2%
Q2 2021$4,389,000
+121.0%
27,110
+9.5%
0.01%
+83.3%
Q1 2021$1,986,000
+48.7%
24,758
+0.8%
0.01%
+50.0%
Q4 2020$1,336,000
+178.3%
24,559
+1.6%
0.00%
+100.0%
Q3 2020$480,000
-4.4%
24,169
+1.0%
0.00%0.0%
Q2 2020$502,000
+40.2%
23,924
-18.5%
0.00%0.0%
Q1 2020$358,000
+11.2%
29,338
+33.3%
0.00%
+100.0%
Q4 2019$322,000
+3.5%
22,002
-5.7%
0.00%0.0%
Q3 2019$311,000
-15.7%
23,325
+3.3%
0.00%
-50.0%
Q2 2019$369,000
+53.1%
22,589
+59.7%
0.00%
+100.0%
Q1 2019$241,000
+62.8%
14,149
+30.2%
0.00%0.0%
Q4 2018$148,000
-42.4%
10,864
+20.7%
0.00%0.0%
Q3 2018$257,000
-0.4%
9,001
-4.4%
0.00%0.0%
Q2 2018$258,000
+26.5%
9,415
-2.8%
0.00%0.0%
Q1 2018$204,0009,6830.00%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
HIMENSION CAPITAL (SINGAPORE) PTE. LTD. 1,216,340$62,958,0007.04%
Discovery Value Fund 584,483$30,253,0006.33%
MPM BioImpact LLC 299,409$15,497,0004.30%
ARK Investment Management 9,514,580$439,003,0002.60%
Elmwood Wealth Management, Inc. 67,899$3,514,0002.00%
Nikko Asset Management Americas, Inc. 2,781,136$141,143,0001.74%
Avidity Partners Management LP 1,125,194$58,240,0001.34%
Merlin Capital, Inc 12,174$630,0001.26%
Atlas Venture Associates IX, LLC 10,000$518,0001.18%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 111,440$5,768,0001.16%
View complete list of INTELLIA THERAPEUTICS INC shareholders